High-dose intravenous pamidronate for metastatic bone pain (Q36079642)

12 August 2017

High-dose intravenous pamidronate for metastatic bone pain (English)

1 reference

12 August 2017

Purohit OP

1

1 reference

12 August 2017

Anthony C

2

1 reference

12 August 2017

Radstone CR

3

1 reference

12 August 2017

Owen J

4

1 reference

12 August 2017

Coleman RE

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

3

1 reference

12 August 2017

554-558

1 reference

Osteoclast inhibition for the treatment of bone metastases

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Clodronate therapy of metastatic bone disease in patients with prostatic carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033374

The Oswestry low back pain disability questionnaire

11 July 2018

1 reference

12 December 2020

Palliative pamidronate treatment in patients with bone metastases from breast cancer

1 reference

12 December 2020

The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases

1 reference

12 December 2020

Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.344

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

8080746

1 reference